Built on science, its products have clinical backing for their impact on digestion and metabolic health, including weight loss and diabetes management
Expert discovery is currently scheduled to close in March 2026, with bellwether trials expected to begin in mid-2026
Retatrutides appetite suppression was among the most potent seen from a multivalent hormone therapy to date
Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice
The US Food and Drug Administration approved Wegovy for chronic weight management for people with a body mass index of 30 or more, or 27 or more for people with a weight-related condition like high blood pressure
The formulation is mixed until a uniform suspension is achieved